LAUSR

1 Tlougan BE, Podjasek JO, O’Haver J et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: A report of seven cases and review of the literature. Pediatr. Dermatol. 2009; 26: 497–505. 2 Kechichian E, Haber R, Mourad N. Pediatric pyoderma gangrenosum: A systematic review and update. Int. J. Dermatol. 2017; 56: 486–95. 3 Nurre LD, Rabalais GP, Callen JP. Neutrophilic dermatosis-associated sterile chronic multifocal osteomyelitis in pediatric patients: Case report and review. Pediatr. Dermatol. 1999; 16: 214–6. 4 Sundaram M, McDonald D, Engel E, Rotman M, Siegfried EC. Chronic recurrent multifocal osteomyelitis: An evolving clinical and radiological spectrum. Skeletal Radiol. 1996; 25: 333–6. 5 Williamson D, Sibbald RG. Chronic recurrent multifocal osteomyelitis: A rare association with pyoderma gangrenosum in adults. Br. J. Dermatol. 2002; 147: 611–3. 6 Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CEM. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J. Dermatolog. Treat. 2001; 12: 13–7. 7 Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. J. Am. Acad. Dermatol. 2005; 53: 273–83. 8 Hubbard VG, Friedmann AC, Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br. J. Dermatol. 2005; 152: 1059–61.